Table 4. Genotype distribution in professional athletes, elite endurance athletes, professional football players and non-athletes for muscle injuries polymorphisms.

Symbol	Gene	Polymorphism	dbSNP	Genotype Score	Professional athletes	Elite endurance athletes	Professional football players	Elite endurance athletes vs. Professional football players p-value	non-athletes	Professional athletes vs. non-athletes p-value	Elite endurance athletes vs. non-athletes p-value	Professional football players vs. non-athletes p-value
ACE	Angiotensin I-converting enzyme	Alu 287bp (I/D)	rs4340	2 = DD	140 (47.9%)	79 (49.4%)	61 (46.2%)	0.175	62 (38.7%)	0.034	0.011	0.216
				1 = ID	114 (39.0%)	56 (35.0%)	58 (43.9%)		82 (51.2%)
				0 = II	38 (13.1%)	25 (15.6%)	13 (9.9%)		16 (10.1%)
ACTN3	α-actinin 3	c.1729C>T	rs1815739	2 = CC	91 (31.2%)	55 (34.4%)	36 (27.3%)	0.211	48 (30.0%)	0.681	0.678	0.410
				1 = TC	150 (51.4%)	82 (51.2%)	68 (51.5%)		91 (56.6%)
				0 = TT	51 (17.4%)	23 (14.4%)	28 (21.2%)		21 (13.4%)
AMPD1	Adenosine Monophosphate Deaminase 1	c.34C>T	rs17602729	2 = CC	233 (79.8%)	128 (80.0%)	105 (79.6%)	0.291	99 (62.1%)	0.006	0.010	0.014
				1 = CT	57 (19.5%)	32 (20.0%)	25 (18.9%)		60 (37.4%)
				0 = TT	2 (0.7%)	0 (0.0%)	2 (1.5%)		1 (0.5%)
CKM	Muscle-specific creatine kinase	c.*800A>G	rs8111989	2 = GG	26 (8.9%)	16 (10.0%)	10 (7.6%)	0.418	10 (5.9%)	0.718	0.326	0.384
				1 = GA	142 (48.6%)	88 (55.0%)	54 (40.9%)		72 (45.3%)
				0 = AA	124 (42.5%)	56 (35.0%)	68 (51.5%)		78 (48.8%)
MLCK	Myosin-light chain kinase	c.37885C>A	rs28497577	2 = AA	1 (0.4%)	0 (0.0%)	1 (0.8%)	0.002	1 (0.6%)	<0.001	<0.001	<0.001
				1 = CA	217 (74.3%)	107 (66.9%)	110 (83.3%)		56 (35.3%)
				0 = CC	74 (25.3%)	53 (33.1%)	21 (15.9%)		103 (64.1%)
MLCK	Myosin-light chain kinase	c.49C>T	rs2700352	2 = CC	167 (57.2%)	79 (49.4%)	88 (66.7%)	0.001	31 (19.6%)	<0.001	<0.001	<0.001
				1 = CT	99 (33.9%)	59 (36.8%)	40 (30.3%)		109 (68.1%)
				0 = TT	26 (8.9%)	22 (13.8%)	4 (3.0%)		20 (12.3%)